Alejandro Sánchez

1.6k total citations
56 papers, 722 citations indexed

About

Alejandro Sánchez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Alejandro Sánchez has authored 56 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 16 papers in Surgery. Recurrent topics in Alejandro Sánchez's work include Renal cell carcinoma treatment (19 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Renal and related cancers (11 papers). Alejandro Sánchez is often cited by papers focused on Renal cell carcinoma treatment (19 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Renal and related cancers (11 papers). Alejandro Sánchez collaborates with scholars based in United States, Germany and Canada. Alejandro Sánchez's co-authors include A. Ari Hakimi, Adam S. Feldman, Robert J. Motzer, Martin H. Voss, Irina Ostrovnaya, Fengshen Kuo, Timothy A. Chan, Lynda Vuong, Parul Patel and Albert Reising and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and American Journal of Clinical Nutrition.

In The Last Decade

Alejandro Sánchez

46 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alejandro Sánchez United States	12	450	276	213	135	115	56	722
Sebastian Hofbauer Austria	19	526 1.2×	147 0.5×	285 1.3×	163 1.2×	269 2.3×	47	994
Serge Brunelle France	17	407 0.9×	134 0.5×	279 1.3×	60 0.4×	265 2.3×	55	1.0k
Hongbing Liu China	14	385 0.9×	178 0.6×	376 1.8×	101 0.7×	60 0.5×	50	716
Jiacheng Yin China	13	393 0.9×	234 0.8×	289 1.4×	155 1.1×	130 1.1×	25	753
Lijie Tan China	15	324 0.7×	203 0.7×	134 0.6×	139 1.0×	249 2.2×	62	781
Wen Kong China	18	425 0.9×	401 1.5×	236 1.1×	251 1.9×	203 1.8×	65	887
Vasile Foris Austria	18	786 1.7×	162 0.6×	136 0.6×	89 0.7×	101 0.9×	54	1.1k

Countries citing papers authored by Alejandro Sánchez

Since Specialization

Citations

This map shows the geographic impact of Alejandro Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Sánchez more than expected).

Fields of papers citing papers by Alejandro Sánchez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Sánchez. The network helps show where Alejandro Sánchez may publish in the future.

Co-authorship network of co-authors of Alejandro Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Sánchez. A scholar is included among the top collaborators of Alejandro Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Sánchez. Alejandro Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maughan, Benjamin L., Christopher Dechet, Julia Beck, et al.. (2025). Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT). Journal for ImmunoTherapy of Cancer. 13(3). e010572–e010572. 1 indexed citations

Kim, Hyung L., Catherine M. Tangen, Ulka N. Vaishampayan, et al.. (2024). SWOG S1931 (PROBE): PHASE III RANDOMIZED TRIAL OF IMMUNE CHECKPOINT INHIBITOR (ICI) COMBINATION REGIMEN WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN) IN ADVANCED RENAL CANCER [NCT04510597]. Urologic Oncology Seminars and Original Investigations. 42. S4–S4. 2 indexed citations

Bradshaw, Patrick T., Alejandro Sánchez, Andrea Knežević, et al.. (2024). Radiodensities of Skeletal Muscle and Visceral Adipose Tissues Are Prognostic Factors in Clear-Cell Renal Cell Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 33(10). 1375–1382.

Hu, Siqi, John Snyder, Vikrant Deshmukh, et al.. (2024). Association of Baseline Pre-Diagnosis and Post-Diagnosis Obesity and Weight Change with Cardiovascular Risk and Survival Among Nonmetastatic Prostate Cancer Survivors. Clinical Genitourinary Cancer. 22(3). 102057–102057.

Furberg, Helena, Patrick T. Bradshaw, Andrea Knežević, et al.. (2024). Skeletal muscle and visceral adipose radiodensities are pre‐surgical, non‐invasive markers of aggressive kidney cancer. Journal of Cachexia Sarcopenia and Muscle. 15(2). 726–734. 8 indexed citations

Espinosa, Ana, Salvador Bará, Alejandro Sánchez, et al.. (2024). Outdoor artificial light-at-night and cardiometabolic disease risk: an urban perspective from the Catalan GCAT cohort study. American Journal of Epidemiology. 194(4). 963–974. 4 indexed citations

Blum, Kyle A., Andrew W. Silagy, Andrea Knežević, et al.. (2023). Localised non‐metastatic sarcomatoid renal cell carcinoma: a 31‐year externally verified study. British Journal of Urology. 133(2). 169–178. 3 indexed citations

Johnson, Jordan M., Enrique Balderas, Elahu G. Sustarsic, et al.. (2023). Mitochondrial phosphatidylethanolamine modulates UCP1 to promote brown adipose thermogenesis. Science Advances. 9(8). eade7864–eade7864. 39 indexed citations

Hu, Siqi, John Snyder, Vikrant Deshmukh, et al.. (2023). Comparing Active Surveillance and Watchful Waiting With Radical Treatment Using Machine Learning Models Among Patients With Prostate Cancer. JCO Clinical Cancer Informatics. 7(7). e2300083–e2300083. 2 indexed citations

10.

Hu, Siqi, John Snyder, Vikrant Deshmukh, et al.. (2023). Mental health outcomes in a population-based cohort of patients with prostate cancer. JNCI Journal of the National Cancer Institute. 116(3). 445–454. 6 indexed citations

11.

Ged, Yasser, Alejandro Sánchez, Sujata Patil, et al.. (2022). Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade. Clinical Cancer Research. 28(23). 5180–5189. 20 indexed citations

12.

Parsons, Maddy, John Peterson, Glen Morrell, et al.. (2022). The Clinical Significance of Maximum Tumor Diameter on MRI in Men Undergoing Radical Prostatectomy or Definitive Radiotherapy for Locoregional Prostate Cancer. Clinical Genitourinary Cancer. 20(6). e453–e459. 2 indexed citations

13.

Mano, Roy, Debra A. Goldman, Kyle A. Blum, et al.. (2021). Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma – An exploratory analysis. Urologic Oncology Seminars and Original Investigations. 39(11). 791.e17–791.e24. 7 indexed citations

14.

Kaufman, Claire, et al.. (2021). Image-Guided Targeted Prostate Biopsies. Techniques in vascular and interventional radiology. 24(4). 100777–100777. 2 indexed citations

15.

Sánchez, Alejandro, et al.. (2020). Impact of body size and body composition on bladder cancer outcomes: Risk stratification and opportunity for novel interventions. Urologic Oncology Seminars and Original Investigations. 38(9). 713–718. 9 indexed citations

16.

Hakimi, A. Ari, Martin H. Voss, Fengshen Kuo, et al.. (2019). Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial. Cancer Discovery. 9(4). 510–525. 156 indexed citations

17.

DiNatale, Renzo G., Wanling Xie, Maria F. Becerra, et al.. (2019). The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy. European Urology Oncology. 3(1). 47–56. 19 indexed citations

18.

Mano, Roy, Jessica Flynn, Kyle A. Blum, et al.. (2019). The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 37(12). 916–923. 9 indexed citations

19.

Sánchez, Alejandro, Helena Furberg, Fengshen Kuo, et al.. (2019). Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study. The Lancet Oncology. 21(2). 283–293. 127 indexed citations

20.

Shoushtari, Alexander N., Jonathan Landa, Deborah Kuk, et al.. (2016). Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma. Sarcoma. 2016. 1–8. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sebastian Hofbauer Breakdown of academic impact, for papers by Serge Brunelle Breakdown of academic impact, for papers by Hongbing Liu Breakdown of academic impact, for papers by Jiacheng Yin Breakdown of academic impact, for papers by Lijie Tan Breakdown of academic impact, for papers by Wen Kong Breakdown of academic impact, for papers by Vasile Foris